11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      KDM6B promotes PARthanatos via suppression of O 6-methylguanine DNA methyltransferase repair and sustained checkpoint response

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Poly(ADP-ribose) polymerase-1 (PARP-1) is a DNA damage sensor and contributes to both DNA repair and cell death processes. However, how PARP-1 signaling is regulated to switch its function from DNA repair to cell death remains largely unknown. Here, we found that PARP-1 plays a central role in alkylating agent-induced PARthanatic cancer cell death. Lysine demethylase 6B (KDM6B) was identified as a key regulator of PARthanatos. Loss of KDM6B protein or its demethylase activity conferred cancer cell resistance to PARthanatic cell death in response to alkylating agents. Mechanistically, KDM6B knockout suppressed methylation at the promoter of O 6-methylguanine-DNA methyltransferase (MGMT) to enhance MGMT expression and its direct DNA repair function, thereby inhibiting DNA damage-evoked PARP-1 hyperactivation and subsequent cell death. Moreover, KDM6B knockout triggered sustained Chk1 phosphorylation and activated a second XRCC1-dependent repair machinery to fix DNA damage evading from MGMT repair. Inhibition of MGMT or checkpoint response re-sensitized KDM6B deficient cells to PARthanatos induced by alkylating agents. These findings provide new molecular insights into epigenetic regulation of PARP-1 signaling mediating DNA repair or cell death and identify KDM6B as a biomarker for prediction of cancer cell vulnerability to alkylating agent treatment.

          Related collections

          Most cited references39

          • Record: found
          • Abstract: found
          • Article: not found

          Genome-scale CRISPR-Cas9 knockout screening in human cells.

          The simplicity of programming the CRISPR (clustered regularly interspaced short palindromic repeats)-associated nuclease Cas9 to modify specific genomic loci suggests a new way to interrogate gene function on a genome-wide scale. We show that lentiviral delivery of a genome-scale CRISPR-Cas9 knockout (GeCKO) library targeting 18,080 genes with 64,751 unique guide sequences enables both negative and positive selection screening in human cells. First, we used the GeCKO library to identify genes essential for cell viability in cancer and pluripotent stem cells. Next, in a melanoma model, we screened for genes whose loss is involved in resistance to vemurafenib, a therapeutic RAF inhibitor. Our highest-ranking candidates include previously validated genes NF1 and MED12, as well as novel hits NF2, CUL3, TADA2B, and TADA1. We observe a high level of consistency between independent guide RNAs targeting the same gene and a high rate of hit confirmation, demonstrating the promise of genome-scale screening with Cas9.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens

            We propose the Model-based Analysis of Genome-wide CRISPR/Cas9 Knockout (MAGeCK) method for prioritizing single-guide RNAs, genes and pathways in genome-scale CRISPR/Cas9 knockout screens. MAGeCK demonstrates better performance compared with existing methods, identifies both positively and negatively selected genes simultaneously, and reports robust results across different experimental conditions. Using public datasets, MAGeCK identified novel essential genes and pathways, including EGFR in vemurafenib-treated A375 cells harboring a BRAF mutation. MAGeCK also detected cell type-specific essential genes, including BCR and ABL1, in KBM7 cells bearing a BCR-ABL fusion, and IGF1R in HL-60 cells, which depends on the insulin signaling pathway for proliferation. Electronic supplementary material The online version of this article (doi:10.1186/s13059-014-0554-4) contains supplementary material, which is available to authorized users.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.

              Poly(ADP-ribose) polymerase (PARP1) facilitates DNA repair by binding to DNA breaks and attracting DNA repair proteins to the site of damage. Nevertheless, PARP1-/- mice are viable, fertile and do not develop early onset tumours. Here, we show that PARP inhibitors trigger gamma-H2AX and RAD51 foci formation. We propose that, in the absence of PARP1, spontaneous single-strand breaks collapse replication forks and trigger homologous recombination for repair. Furthermore, we show that BRCA2-deficient cells, as a result of their deficiency in homologous recombination, are acutely sensitive to PARP inhibitors, presumably because resultant collapsed replication forks are no longer repaired. Thus, PARP1 activity is essential in homologous recombination-deficient BRCA2 mutant cells. We exploit this requirement in order to kill BRCA2-deficient tumours by PARP inhibition alone. Treatment with PARP inhibitors is likely to be highly tumour specific, because only the tumours (which are BRCA2-/-) in BRCA2+/- patients are defective in homologous recombination. The use of an inhibitor of a DNA repair enzyme alone to selectively kill a tumour, in the absence of an exogenous DNA-damaging agent, represents a new concept in cancer treatment.
                Bookmark

                Author and article information

                Contributors
                Journal
                Nucleic Acids Res
                Nucleic Acids Res
                nar
                Nucleic Acids Research
                Oxford University Press
                0305-1048
                1362-4962
                24 June 2022
                01 June 2022
                01 June 2022
                : 50
                : 11
                : 6313-6331
                Affiliations
                Department of Pathology, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA
                Department of Pathology, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA
                Department of Pathology, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA
                Department of Pathology, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA
                Department of Pathology, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA
                Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA
                Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA
                Department of Bioinformatics, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA
                Department of Population and Data Sciences, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA
                Department of Pathology, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA
                Department of Pharmacology, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA
                Department of Pathology, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA
                Department of Neurology, University of Texas Southwestern Medical Center , Dallas, TX 75390, USA
                Peter O’Donnell Brain Institute, UT Southwestern Medical Center , Dallas, TX 75390, USA
                Author notes
                To whom correspondence should be addressed. Tel: +1 214 645 7961; Email: yingfei.wang@ 123456utsouthwestern.edu

                The authors wish it to be known that, in their opinion, the first two authors should be regarded as Joint First Authors.

                Author information
                https://orcid.org/0000-0002-1992-0320
                https://orcid.org/0000-0002-8723-252X
                Article
                gkac471
                10.1093/nar/gkac471
                9226499
                35648484
                52a97ba3-5aab-4882-afb5-0c199b2fa89a
                © The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@ 123456oup.com

                History
                : 17 May 2022
                : 18 April 2022
                : 20 December 2021
                Page count
                Pages: 19
                Funding
                Funded by: National Institutes of Health, DOI 10.13039/100000002;
                Award ID: R35GM124693
                Award ID: R00NS078049
                Award ID: R01AG066166
                Funded by: Welch foundation, DOI 10.13039/100000928;
                Award ID: I-1939
                Funded by: University of Texas;
                Funded by: UT Rising Stars;
                Funded by: NIH, DOI 10.13039/100000002;
                Award ID: R01CA222393
                Funded by: CRPIT;
                Award ID: RP190358
                Funded by: Welch Foundation, DOI 10.13039/100000928;
                Award ID: I-1903
                Categories
                AcademicSubjects/SCI00010
                Molecular Biology

                Genetics
                Genetics

                Comments

                Comment on this article